GLP-1 Weight Loss
Compounded Tirzepatide
Reconstitution & Dosing Guide
Dual GIP and GLP-1 receptor agonist delivering superior glycemic control and clinical weight reduction.
Standard Vial Size:10 mg
Recommended BAC Water:2.0 mL
Refrigerated Stability:28 Days
Elimination Half-Life:120 Hours
Standard Titration & Syringe Unit Chart (10mg Vial + 2mL Water)
Concentration produces exactly 5.00 mg/mL (5,000 mcg/mL).
| Protocol Step / Dose | Target (mcg) | U-100 Syringe Units | Total Doses |
|---|---|---|---|
| 2.5 mg (Starting W1-4) | 2500 mcg | 50.0 Units | 4 doses |
| 5.0 mg (Maintenance W5-8) | 5000 mcg | 100.0 Units | 2 doses |
| 7.5 mg (Titration W9-12) | 7500 mcg | 150.0 Units | 1 doses |
| 10.0 mg (Therapeutic) | 10000 mcg | 200.0 Units | 1 doses |
| 15.0 mg (Maximum Dose) | 15000 mcg | 300.0 Units | 0 doses |
Mixing & Handling Protocol
Reconstitute with 2.0 mL or 3.0 mL of BAC water to keep injection volume comfortable under 50 units.
Initial Protocol Target (2500 mcg)
50.0UNITS
Draw to the 50.0-unit mark on a standard 1.0 mL U-100 syringe.
Yields 4 complete doses per vial.Precision Syringe GaugeU-100 Standard Insulin Barrel
50.0 Units(50% Capacity)
0
10
20
30
40
50
60
70
80
90
100
◄ Luer Needle HubAlign black stopper edge to 50.0 linePlunger Flange ►
Advertisement & Sponsored Resource
High-RPM Health Sponsorship PlacementTargeting GLP-1 & Longevity Patient Audience